Prostin E2 V Tab 3MG Indications
Prostin E2 V Tab 3MG is primarily indicated in conditions like Abortion, Hydatidiform mole, Labor induction, Uterine atonia.
Side EffectsÂ
The severe or irreversible adverse effects of Prostin E2 V Tab 3MG, which give rise to further complications include Severe pain, Acute fetal distress.,Prostin E2 V Tab 3MG produces potentially life-threatening effects which include Cardiogenic collapse. which are responsible for the discontinuation of Prostin E2 V Tab 3MG therapy.,The signs and symptoms that are produced after the acute overdosage of Prostin E2 V Tab 3MG include Uterine hypertonus.,The symptomatic adverse reactions produced by Prostin E2 V Tab 3MG are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Vomiting, Diarrhea, Erythema, Flushing, Syncope, Vaginal burning, Pallor, Transient pyrexia.
ContraindicationÂ
Prostin E2 V Tab 3MG is contraindicated in conditions like Asthma, Glucoma, Hepatic disease,Pulmonary disease, Pelvic inflammatory disease.
Warning
Prostin E2 V Tab 3MG should be used with caution in patients with medical history, including any allergy (especially drug allergy), pelvic infections, heart, lungs, kidney or liver diseases, high or low blood pressure, anemia, cervicitis, diabetes mellitus, acute vaginitis, infected endocervical lesions, compromised uterus, or a history of asthma, hypertension, hypotension, epilepsy or other seizure disorder, or jaundice. It should not be used at term if patient have a history of caesarean section or major surgery, in patient with vasa previa or who have had unexplained vaginal bleeding during their course of pregnancy. It should not be used in case of abnormal fetal position, cephalopelvic disproportion or signs of fetal distress. Maternal problems such as a history of difficult labor or traumatic delivery, grand multiparity, or any hyperactive or hypertonic uterine patterns indicate that Prostin E2 V Tab 3MG should not be used.
Reviews
There are no reviews yet.